DATE: October 7, 2026 at 05:00PM
SOURCE: STAT NEWS NEUROSCIENCE
TITLE: STAT+: In small trial, optogenetics restores some vision lost to retinitis pigmentosa
Retinitis pigmentosa is a genetic disorder that causes degeneration of the light-sensing cells in the retina. Generally diagnosed in childhood or early adolescence, patients gradually lose peripheral and night vision, often becoming legally blind by young adulthood.
With the exception of a subset of patients who present a specific genetic mutation and can be treated with gene therapy, there is no cure for the condition. Cases are addressed by measures to slow degeneration and preserve what is left of the vision.
Optogenetics — the technology just recognized with a Nobel Prize — could offer hope, according to a new paper published on Wednesday in the New England Journal of Medicine.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/topic/neuroscience .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Optogenetics #RetinitisPigmentosa #VisionRestoration #Neuroscience #GeneTherapy #EyeHealth #BlindnessTreatment #NEJM #VisionTech #STATNews
